Giles Davies

698 citations
14 papers · 553 indexed · h-index 12
Topics
Estrogen and related hormone effects (4 papers)Inflammatory mediators and NSAID effects (4 papers)Cancer, Stress, Anesthesia, and Immune Response (3 papers)

In The Last Decade

Giles Davies

14 papers receiving 536 citations

Peers

Giles Davies
Comparison fields: 5 of 81
  • Pharmacology 176
  • Oncology 160
  • Genetics 157
  • Surgery 134
  • Cancer Research 121
Replace Yoshimi Kakiuchi with:
Yoshimi Kakiuchi Japan
Angela Shoher United States
Eijiro Okajima Japan
Masato Komori Japan
Kenji Hatano Japan
Farhat V. N. Din United Kingdom
K Hay Canada
Michael Nicks United States
N. Mahmoud United States
Atsushi Kawabe Japan
Giles Davies relative to Yoshimi Kakiuchi Japan Yoshimi Kakiuchi's profile →
Citations per field
00.5×2.6×
Yoshimi Kakiuchi · 1×
Citations per year

Countries citing papers authored by Giles Davies

Since Specialization
Citations

This map shows the geographic impact of Giles Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giles Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giles Davies more than expected).

Fields of papers citing papers by Giles Davies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giles Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giles Davies. The network helps show where Giles Davies may publish in the future.

Co-authorship network of co-authors of Giles Davies

This figure shows the co-authorship network connecting the top 25 collaborators of Giles Davies. A scholar is included among the top collaborators of Giles Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giles Davies. Giles Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 28
2 69
3 36
4 1
5 1
6 30
7 34
8 17
9 20
10 35
11
Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer.
111
12 23
13 123
14 25

About Giles Davies

Giles Davies is a scholar working on Pharmacology, Cancer Research and Psychiatry and Mental health, having authored 14 papers that have together received 553 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). The work is most often cited by research in Pharmacology (176 citations), Cancer Research (121 citations) and Oncology (160 citations). Giles Davies has collaborated with scholars based in United Kingdom, Australia and Qatar. Frequent co-authors include Mitch Dowsett, Lesley‐Ann Martin, N Sacks, Janine Salter, Nigel Sacks, Margaret Hills, G. Hossein Ashrafi, K Chong, Melissa Bochner and James Kollias. Their work appears in journals such as Scientific Reports, Annals of Oncology and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026